Enrollment Tops 1,600 in Natera’s EXPAND Trial of Single Gene NIPT
EXPAND is a prospective, blinded, multi-site clinical trial with diagnostic outcomes on all subjects AUSTIN, Texas–(BUSINESS WIRE)–Natera, Inc.…
Browsing Category